<ѻýҕl>ARB-Cancer Link May Come Down to Cumulative Exposureѻýҕl> Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
<ѻýҕl>Early Clinical Activity With CDK4/6 Inhibitor in Pretreated Mesotheliomaѻýҕl> Disease control in 54% of patients in first clinical evaluation of abemaciclib Feb 17, 2022
<ѻýҕl>Long-Term Survival Benefit in NSCLC With Another Anti-PD-1/L1 Drugѻýҕl> Significant improvements in OS, PFS with durvalumab after CRT for unresectable disease Feb 15, 2022
<ѻýҕl>Bevacizumab Add-On No Help in Progressive EGFR-Mutant Lung Cancerѻýҕl> Single-agent osimertinib prevails in progressive, T790M-positive NSCLC Dec 02, 2021
<ѻýҕl>Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicityѻýҕl> No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease Nov 02, 2021
<ѻýҕl>Targeted RT Boosts PFS in Oligoprogressive Lung Cancerѻýҕl> Fivefold improvement in NSCLC but no benefit in oligoprogressive breast cancer Oct 25, 2021
<ѻýҕl>'You're Still Doing WHAT After Lung Cancer Surgery?!'ѻýҕl> But don't give up on hardened smokers, researcher urges Oct 19, 2021
<ѻýҕl>Radiation or Surgery in Early Lung Cancer: Does It Make a Difference?ѻýҕl> Ablative radiation still noninferior to VATS after longer follow-up Sep 24, 2021
<ѻýҕl>How Many Deaths Will New Cigarette Warnings Prevent?ѻýҕl> Modeling study comes up with big numbers Sep 24, 2021
<ѻýҕl>Another Possible Option for HER2-Mutated Non-Small Cell Lung Cancerѻýҕl> More than half of patients responded to antibody-drug conjugate targeting HER2 Sep 19, 2021
<ѻýҕl>More Help on the Way for Lung Cancers With Exon 20 Mutations?ѻýҕl> Early trials of DZD9008 demonstrated responses in over a third of patients Sep 15, 2021
<ѻýҕl>Cancer Vaccine May Boost Anti-EGFR Efficacy in Non-Small Cell Lung Cancerѻýҕl> More than 90% disease control rate, hint of improved PFS in pilot trial Sep 14, 2021
<ѻýҕl>Novel ADC Promising in Certain Non-Squamous Lung Cancersѻýҕl> Response rate topped 50% in patients with EGFR wild-type tumors and high MET expression Sep 14, 2021
<ѻýҕl>More Data in Support of Surgery for Malignant Pleural Mesotheliomaѻýҕl> Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
<ѻýҕl>Meta-Analysis Confirms Benefits of Low-Dose CT Screening for Lung Cancerѻýҕl> LDCT associated with a 16% relative reduction in mortality versus no screening Sep 13, 2021
<ѻýҕl>Immuno-Oncology Combo Active in Recurrent EGFR/ALK Positive NSCLCѻýҕl> Responses in 42% of EGFR group, limited activity in ALK-rearranged lung cancer Sep 12, 2021
<ѻýҕl>Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesotheliomaѻýҕl> Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
<ѻýҕl>Durable Response with Immunotherapy Combos in NSCLC with Brain Metastasesѻýҕl> Analysis of CheckMate 9LA data and phase II study from Spain offer hope in advanced disease Sep 12, 2021
<ѻýҕl>Study Sheds Light on Physician-Assisted Suicide in Lung Cancer Patientsѻýҕl> Patients often did not consult with radiation or medical oncologists Sep 09, 2021
<ѻýҕl>Second-Line Combo Fails to Improve Survival in SCLCѻýҕl> No OS difference, but lurbinectedin-doxorubicin was less toxic than standard chemotherapy options Sep 09, 2021
<ѻýҕl>High Response Rate in Non-Small Cell Lung Cancer With RET Inhibitorѻýҕl> Responses in 66-80% of patients from China confirm activity of pralsetinib Sep 09, 2021
<ѻýҕl>TROP2 Antibody-Drug Conjugate Shows Promise in Lung Cancerѻýҕl> Disease control observed in over two-thirds of patients at selected dose Sep 08, 2021
<ѻýҕl>Another Ivermectin Flop; 'Instant' Lung Cancer Decision Tool; Triple COPD Tx & Deathѻýҕl> Highlights from the European Respiratory Society virtual meeting Sep 08, 2021
<ѻýҕl>No Survival Bump With PARP Inhibitor in Squamous NSCLCѻýҕl> Possible benefit in tumors with positive lung cancer-specific gene panel Sep 07, 2021
<ѻýҕl>AI Blood Test Proves Useful in Lung Cancer Detectionѻýҕl> Such an approach would be useful considering the barriers to LDCT among high-risk people Aug 25, 2021
<ѻýҕl>Avoiding Hippocampus in Brain RT May Help Preserve Cognitive Functionѻýҕl> Recall metrics favored hippocampal avoidance at all time points, with no increase in brain mets Aug 13, 2021
<ѻýҕl>Kathy Griffin's Early-Stage Lung Cancerѻýҕl> A closer look at diagnosis in "never-smokers" Aug 09, 2021
<ѻýҕl>Drug Combo Promising in Rare Mesotheliomaѻýҕl> Small study showed "robust and durable" responses, with "meaningful prolongation of survival" Jul 19, 2021
<ѻýҕl>Juul Bought Out Medical Journal for $51Kѻýҕl> E-cig maker sponsored nearly a dozen studies, took over journal as it awaits FDA ruling Jul 13, 2021
<ѻýҕl>LDCT Screening Linked to Lower Risk of Brain Mets in Lung Cancerѻýҕl> This observed reduction in risk may be due to a less aggressive tumor biology, said study author Jun 28, 2021
<ѻýҕl>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻýҕl> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻýҕl>Bispecific Antibody Active in NRG1-Positive Pancreatic Cancerѻýҕl> Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
<ѻýҕl>Combination Shows Promise in Post-Osimertinib Lung Cancerѻýҕl> Responses in 36% with amivantamab-lazertinib, 47% with EGFR/MET resistance Jun 06, 2021
<ѻýҕl>Antibody-Drug Conjugate Active in Resistant Lung Cancerѻýҕl> Responses in 39% of EGFR inhibitor-resistant patients with patritumab deruxtecan Jun 05, 2021
<ѻýҕl>Chemoimmunotherapy Tied to Better Outcomes in Advanced NSCLCѻýҕl> PD-L1 status and age play key roles in success of combined regimen versus immunotherapy alone Jun 05, 2021
<ѻýҕl>Lymph Node Findings on PET: Cancer or COVID Vaccine?ѻýҕl> Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<ѻýҕl>Anti-PD-L1 Plus SBRT Enhances Major Responses in Early NSCLCѻýҕl> Neoadjuvant combo needs to be validated in a larger randomized trial May 20, 2021
<ѻýҕl>PD-L1 Inhibitor Thwarts Recurrence in Early Lung Cancerѻýҕl> Risk of death, recurrence 34% lower with atezolizumab after surgery and chemo May 19, 2021
<ѻýҕl>Op-Ed: Is FDA's Cigarette Ban Just Smoke and Menthols?ѻýҕl> Actually implementing a ban on menthol cigarettes and cigars could take years May 03, 2021
<ѻýҕl>SBRT Safe for Cancer Patients With Multiple Metastasesѻýҕl> Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021